Hypercvad Plus Imatinib or Dasatinib for Patients with Lymphoid Blastic Phase of Chronic Myeloid Leukemia

被引：0
|
作者：
Strati, Paolo [1 ]
Kantarjian, Hagop M. [1 ]
Thomas, Deborah A. [1 ]
O'Brien, Susan M. [1 ]
Jabbour, Elias J. [1 ]
Quintas-Cardama, Alfonso [1 ]
Borthakur, Gautam [1 ]
Faderl, Stefan [1 ]
Ravandi, Farhad [1 ]
Cortes, Jorge E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3766.3766
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3766
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial
    Apperley, Jane F.
    Cortes, Jorge E.
    Kim, Dong-Wook
    Roy, Lydia
    Roboz, Gail J.
    Rosti, Gianantonio
    Bullorsky, Eduardo O.
    Abruzzese, Elisabetta
    Hochhaus, Andreas
    Heim, Dominik
    de Souza, Carmino A.
    Larson, Richard A.
    Lipton, Jeffrey H.
    Khoury, H. Jean
    Kim, Hyeoung-Joon
    Sillaber, Christian
    Hughes, Timothy P.
    Erben, Philipp
    Van Tornout, Jan
    Stone, Richard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3472 - 3479
  • [42] DASATINIB, HIGH-DOSE IMATINIB AND NILOTINIB IN CHINESE PATIENTS WITH CHRONIC PHASE OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB-RESISTANCE OR -INTOLERANCE: AN ECONOMIC EVALUATION
    Wu, B.
    VALUE IN HEALTH, 2015, 18 (07) : A460 - A460
  • [43] Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy
    Rytting, ME
    Wierda, WG
    LEUKEMIA & LYMPHOMA, 2004, 45 (08) : 1623 - 1626
  • [44] DASATINIB FRONTLINE IN ELDERLY PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA
    Stagno, F.
    Breccia, M.
    Annunziata, M.
    Trawinska, M.
    Iurlo, A.
    Sgherza, N.
    Fava, C.
    Gozzini, A.
    Luciano, L.
    Bonifacio, M.
    Sora, F.
    Crescenzi, S. Leonetti
    Bocchia, M.
    Crugnola, M.
    Gugliotta, G.
    Capodanno, I.
    Galimberti, S.
    Feo, C.
    Porrini, R.
    Pregno, P.
    Tiribelli, M.
    Rizzo, M.
    Mauro, E.
    Antolino, A.
    Rossi, A. Russo
    Guarini, A.
    Abruzzese, E.
    Vigneri, P.
    Latagliata, R.
    HAEMATOLOGICA, 2017, 102 : 90 - 91
  • [45] Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia
    A Spencer
    T Vulliamy
    J Kaeda
    JM Goldman
    JV Melo
    Leukemia, 1997, 11 : 195 - 201
  • [46] Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia
    Spencer, A
    Vulliamy, T
    Kaeda, J
    Goldman, JM
    Melo, JV
    LEUKEMIA, 1997, 11 (02) : 195 - 201
  • [47] IMMUNOPHENOTYPE OF CHRONIC MYELOID-LEUKEMIA BLASTIC PHASE
    LOPEZKARPOVITCH, X
    CARDENAS, MR
    PIEDRAS, J
    BLOOD, 1994, 84 (10) : A633 - A633
  • [48] Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy
    Liu, Yujie
    Tu, Yuqing
    Xiao, Jinyan
    Shen, Yifan
    Zhou, Biqi
    Yang, Qiannan
    Yu, Lei
    Qi, Lijuan
    Chen, Jia
    Liu, Tianhui
    Wu, Depei
    Xu, Yang
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [49] Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
    Hoyle, Martin
    Rogers, Gabriel
    Moxham, Tiffany
    Liu, Zulian
    Stein, Ken
    VALUE IN HEALTH, 2011, 14 (08) : 1057 - 1067
  • [50] Imatinib Intolerance Is Associated With Blastic Phase Development in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    Luis Angeles-Velazquez, Jorge
    Hurtado-Monroy, Rafael
    Vargas-Viveros, Pablo
    Carrillo-Munoz, Silvia
    Candelaria-Hernandez, Myrna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 : S82 - S85
12345